<bill session="112" type="s" number="733" updated="2019-02-20T23:03:24Z">
  <state datetime="2011-04-05">REFERRED</state>
  <status>
    <introduced datetime="2011-04-05"/>
  </status>
  <introduced datetime="2011-04-05"/>
  <titles>
    <title type="display">A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.</title>
    <title type="official" as="introduced">A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare.</title>
  </titles>
  <sponsor bioguide_id="R000307"/>
  <cosponsors>
    <cosponsor bioguide_id="C001070" joined="2011-04-12"/>
    <cosponsor bioguide_id="H001049" joined="2011-06-22"/>
    <cosponsor bioguide_id="S000770" joined="2011-04-05"/>
  </cosponsors>
  <actions>
    <action datetime="2011-04-05">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2011-04-05">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S2139-2140"/>
    </action>
    <action datetime="2011-04-05" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
      <reference ref="CR S2140" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="112" type="h" number="905" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2011-05-27T21:28:51Z" status="Introduced in Senate">Amends part B (Supplementary Medical Insurance) of title XVIII (Medicare) of the Social Security Act to exclude from the average sales price in calculating Medicare payments for drugs and biologicals any customary prompt pay discounts from manufacturers to wholesalers.</summary>
</bill>
